EP2092069
Breyttir leysanlegir FGF viðtaka Fc samrunar með aukinni líffræðilegri virkni.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.11.2007EP published:
11.5.2011EP application number:
07866627.8
EP translation filed:
9.8.2011Grant published:
15.9.2011EPO information:
European Patent Register
Max expiry date:
27.11.2027Expiry date:
27.11.2014
Title:
MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL ACTIVITY
Timeline
Today
28.11.2007EP application
11.5.2011EP Publication
9.8.2011Translation submitted
15.9.2011Registration published
27.11.2014Expires
Owner
Name:
Aventis Pharma S.A.Address:
20, avenue Raymond Aron, 92160, Antony, FR
Inventor
Name:
NESBIT, MarkAddress:
Paris, FR
Name:
CAMERON, BéatriceAddress:
Paris, FR
Name:
BLANCHE, FrancisAddress:
Paris, FR
Name:
SORDELLO, SylvieAddress:
Paris, FR
Name:
NICOLAZZI, CélineAddress:
Paris, FR
Name:
TROMBE, MarcAddress:
Paris, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
06291824Date:
28.11.2006Country:
EP
Number:
07290042Date:
11.1.2007Country:
EP
Classification
Categories:
C12N 15/62, A61K 38/17, A61K 47/48, C07K 14/47, C07K 14/71
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.10.2011
Expires: 27.11.2012
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 5.10.2012
Expires: 27.11.2013
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 9.10.2013
Expires: 27.11.2014
Payer: Árnason Faktor